z-logo
open-access-imgOpen Access
Netrin-1 up-regulation in inflammatory bowel diseases is required for colorectal cancer progression
Author(s) -
Andrea Paradisi,
Carine Maisse,
Marie–May Coissieux,
Nicolas Gadot,
Florian Lépinasse,
Céline DelloyeBourgeois,
JeanGuy Delcros,
Magali Svrcek,
Clemens Neufert,
Jean–François Fléjou,
JeanYves Scoazec,
Patrick Mehlen
Publication year - 2009
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.0901767106
Subject(s) - colorectal cancer , mouse model of colorectal and intestinal cancer , inflammatory bowel disease , netrin , ulcerative colitis , autocrine signalling , inflammation , medicine , cancer , cancer research , pathogenesis , deleted in colorectal cancer , immunology , colitis , receptor , disease , axon guidance
Chronic inflammation and cancer are intimately associated. This is particularly true for inflammatory bowel diseases (IBD), such as ulcerative colitis and Crohn's disease, which show a major increased risk for colorectal cancer. While the understanding of the molecular pathogenesis of IBD has recently improved, the mechanisms that link these chronic inflammatory states to colorectal cancer development are in large part unknown. One of these mechanisms is NF-kappaB pathway activation which in turn may contribute to tumor formation by providing anti-apoptotic survival signals to the epithelial cells. Based on the observation that netrin-1, the anti-apoptotic ligand for the dependence receptors DCC and UNC5H is up-regulated in colonic crypts in response to NF-kappaB, we show here that colorectal cancers from inflammatory bowel diseases patients have selected up-regulation of netrin-1. Moreover, we demonstrate that this inflammation-driven netrin-1 up-regulation is causal for colorectal cancer development as interference with netrin-1 autocrine loop in a mouse model for ulcerative colitis-associated colorectal cancer, while showing no effect on inflammation, inhibits colorectal cancer progression.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom